- Home
- OKYO vs PCM Comparison
OKYO vs PCM Comparison
Compare OKYO & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OKYO | PCM |
|---|---|---|
| Founded | 2007 | 1993 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 82.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | OKYO | PCM |
|---|---|---|
| Price | $1.59 | $5.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.33 | N/A |
| AVG Volume (30 Days) | 43.0K | ★ 45.5K |
| Earning Date | 07-18-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $5.52 |
| 52 Week High | $3.35 | $6.76 |
Technical Indicators
Market Signals| Indicator | OKYO | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 40.19 |
| Support Level | $1.58 | $5.52 |
| Resistance Level | $1.73 | $6.12 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 32.86 | 10.67 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.